美股异动丨BioNTech跌超6%，消息称辉瑞寻求出售持股套现超5亿美元

Core Viewpoint - Pfizer is seeking to sell its remaining stake in its COVID-19 vaccine partner BioNTech, which is expected to generate up to approximately $508 million in proceeds for Pfizer [1] Group 1 - BioNTech's stock price dropped over 6% to $104.7 following the news of Pfizer's planned stake sale [1] - BioNTech stated that its collaboration with Pfizer remains unchanged and refrained from commenting on Pfizer's capital market activities [1]